Get the Stockscreener App
4.61
7.24%
-0.36
After Hours:
4.65
0.04
+0.87%
Prenetics Global Limited stock is currently priced at $4.61, with a 24-hour trading volume of 69,005.
It has seen a -7.24% decreased in the last 24 hours and a +29.49% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $4.89 pivot point. If it approaches the $4.43 support level, significant changes may occur.
Previous Close:
$4.97
Open:
$4.86
24h Volume:
69,005
Market Cap:
$56.27M
Revenue:
$291.44M
Net Income/Loss:
$-44.17M
P/E Ratio:
-11.24
EPS:
-0.41
Net Cash Flow:
-
1W Performance:
+58.97%
1M Performance:
+29.49%
6M Performance:
+1,097%
1Y Performance:
+469.07%
1D Range:
$4.56
$4.9243
52W Range:
$0.2865
$7.838
Prenetics Global Limited Stock (PRE) Company Profile
Name
Prenetics Global Limited
Sector
Industry
Phone
852 2210 9588
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay
Prenetics Global Limited Stock (PRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-23 | Initiated | Cantor Fitzgerald | Overweight |
Prenetics Global Limited Stock (PRE) Latest News
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
GlobeNewswire Inc.
Prenetics Announces Third Quarter 2023 Financial Results
GlobeNewswire Inc.
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Benzinga
Prenetics Global Limited Announces Reverse Stock Split
GlobeNewswire Inc.
Prenetics Global Limited Stock (PRE) Financials Data
Prenetics Global Limited (PRE) Revenue 2024
PRE reported a revenue (TTM) of $291.44 million for the quarter ending September 30, 2023, a +76.37% rise year-over-year.
Prenetics Global Limited (PRE) Net Income 2024
PRE net income (TTM) was -$44.17 million for the quarter ending September 30, 2023, a +84.10% increase year-over-year.
Prenetics Global Limited (PRE) Earnings per Share 2024
PRE earnings per share (TTM) was -$4.20 for the quarter ending September 30, 2023, a +93.32% growth year-over-year.
About Prenetics Global Limited
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
0.03%
Cap:
|
Volume (24h):